CCL20 抗体 (AA 28-97) (HRP)
Our Local Distributor
北京 101111
Quick Overview for CCL20 抗体 (AA 28-97) (HRP) (ABIN7978602)
抗原
See all CCL20 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 28-97
-
原理
- Anti-MIP-3 Alpha/CCL20 Antibody HRP Conjugated
-
特异性
- No cross reactivity with other proteins.
-
交叉反应 (详细)
- No cross-reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E. coli-derived mouse MIP-3 Alpha/CCL20 recombinant protein (Position: A28-M97).
-
亚型
- IgG
-
-
-
-
应用备注
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
有效期
- 12 months
-
-
- CCL20 (Chemokine (C-C Motif) Ligand 20 (CCL20))
-
别名
- Ccl20
-
背景
-
Background: Macrophage Inflammatory Protein 3alpha (MIP3alpha), also called Chemokine, cc motif, ligand 20 (CCL20). The MIP-3alpha/CCL20 gene was cloned and sequenced, revealing a four exon, three intron structure, and was localized by FISH analysis to 2q35-q36. MIP3alpha is predominantly expressed in lymph nodes, appendix, PBL, fetal liver, fetal lung and several cell lines. MIP3alpha/CCL20 and its receptor CCR6 are markedly up-regulated in psoriasis, and they may play a role in the recruitment of T cells to lesional psoriatic skin. And Alanine MIP-3alpha and Serine MIP-3alpha, the two forms of MIP3alpha, that differ by one amino acid at the predicted signal peptide cleavage site. Both of them were chemically synthesized and tested for biological activity. And both flu antigen plus IL-2-activated CD4 (+) and CD8 (+) T lymphoblasts and cord blood-derived dendritic cells responded to Ser and Ala MIP-3alpha.
Gene Full Name: C-C motif chemokine ligand 20
-
基因ID
- 20297
-
UniProt
- O89093
-
途径
- The Global Phosphorylation Landscape of SARS-CoV-2 Infection
抗原
-